The Epidemiology of Myasthenia Gravis in Korea
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Purpose: An epidemiological study of myasthenia gravis (MG) has not been performed in Korea. The purpose of this study was to estimate the prevalence and incidence of MG in Korea. Materials and Methods: Health Insurance Review and Assessment (HIRA) data from 2010 to 2014 were searched for MG codes as defined by the International Classification of Diseases, 10th revision. After identifying MG cases, we estimated the prevalence and annual incidence of MG based on the HIRA database and Korean population data. Results: During the study period, 10138 MG cases were identified. The prevalence of MG was 10.42 cases per 100000 people in 2010 and this increased every year to 12.99 cases per 100000 people in 2014. The average incidence of MG between 2011 and 2014 was 0.69 cases per 100000 person-years. The prevalence and incidence were higher in the older (≥50 years) age group than in the younger (<50 years) age group [prevalence: 9.26 vs. 19.24 per 100000, relative risk 2.077, 95% confidence interval (CI) 1.976–2.183, p<0.001; incidence: 0.47 vs. 1.18 per 100000, relative risk 2.490, 95% CI 2.006–3.091, p<0.001]. Conclusion: This study was the first nationwide population-based epidemiological study of MG in Korea. The prevalence and incidenceof MG were consistent with those of previous studies. We found an increase in the prevalence of MG and a predominanceof elderly MG patients.
Abstract
Purpose: An epidemiological study of myasthenia gravis (MG) has not been performed in Korea. The purpose of this study was to estimate the prevalence and incidence of MG in Korea. Materials and Methods: Health Insurance Review and Assessment (HIRA) data from 2010 to 2014 were searched for MG codes as defined by the International Classification of Diseases, 10th revision. After identifying MG cases, we estimated the prevalence and annual incidence of MG based on the HIRA database and Korean population data. Results: During the study period, 10138 MG cases were identified. The prevalence of MG was 10.42 cases per 100000 people in 2010 and this increased every year to 12.99 cases per 100000 people in 2014. The average incidence of MG between 2011 and 2014 was 0.69 cases per 100000 person-years. The prevalence and incidence were higher in the older (≥50 years) age group than in the younger (<50 years) age group [prevalence: 9.26 vs. 19.24 per 100000, relative risk 2.077, 95% confidence interval (CI) 1.976–2.183, p<0.001; incidence: 0.47 vs. 1.18 per 100000, relative risk 2.490, 95% CI 2.006–3.091, p<0.001]. Conclusion: This study was the first nationwide population-based epidemiological study of MG in Korea. The prevalence and incidenceof MG were consistent with those of previous studies. We found an increase in the prevalence of MG and a predominanceof elderly MG patients.
참고문헌 (20)
- Lewis RA, "Myasthenia gravis: immunological mechanisms and immunotherapy", Ann Neurol, 37(Suppl 1), pp.S51~S62 (1995)
- Meriggioli MN, "Autoimmune myasthenia gravis:emerging clinical and biological heterogeneity", Lancet Neurol, 8, pp.475~490 (2009)
- Carr AS, "A systematic review of population based epidemiological studies in Myasthenia Gravis", BMC Neurol, 10, pp.46~ (2010)
- Kim L, "A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples", Epidemiol Health, 36, pp.e2014008~ (2014)
- Kim NH, "Prevalence of multiple sclerosis in Korea", Neurology, 75, pp.1432~1438 (2010)
- Cheong C, "Prevalence and healthcare utilization of herpes zoster and postherpetic neuralgia in South Korea: disparity among patients with different immune statuses", Epidemiol Health, 36, pp.e2014012~ (2014)
- Kim HS, "Current Status of Huntington’s Disease in Korea: A Nationwide Survey and National Registry Analysis", J Mov Disord, 8, pp.14~20 (2015)
- McGrogan A, "The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review", Neuroepidemiology, 32, pp.150~163 (2009)
- Phillips LH, "The epidemiology of myasthenia gravis", Semin Neurol, 24, pp.17~20 (2004)
- Oöpik M, "A population based epidemiological study on myasthenia gravis in Estonia", J Neurol Neurosurg Psychiatry, 74, pp.1638~1643 (2003)
- Lai CH, "Nationwide population-based epidemiological study of myasthenia gravis in taiwan", Neuroepidemiology, 35, pp.66~71 (2010)
- Aarli JA, "Late-onset myasthenia gravis: a changing scene", Arch Neurol, 56, pp.25~27 (1999)
- Murai H, "Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey", J Neurol Sci, 305, pp.97~102 (2011)
- Vincent A, "Evidence of underdiagnosis of myasthenia gravis in older people", J Neurol Neurosurg Psychiatry, 74, pp.1105~1108 (2003)
- Zivkovic´ SA, "Characteristics of late-onset myasthenia gravis", J Neurol, 259, pp.2167~2171 (2012)
- "Is Korea ready for the demographic revolution? The World’s Most Rapidly Aging Society with the Most Rapidly Declining Fertility Rate"[URL]
- Ansar Ahmed S, "Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action", Am J Pathol, 121, pp.531~551 (1985)
- Delpy L, "Estrogen enhances susceptibility to experimental auto-immune myasthenia gravis by promoting type 1-polarized immune responses", J Immunol, 175, pp.5050~5057 (2005)
- Leker RR, "Exacerbation of myasthenia gravis during the menstrual period", J Neurol Sci, 156, pp.107~111 (1998)
- Djelmis J, "Myasthenia gravis in pregnancy: report on 69 cases", Eur J Obstet Gynecol Reprod Biol, 104, pp.21~25 (2002)